Neurotech Pharmaceuticals
900 Highland Corporate Drive, Building 1
Cumberland
RI
02864
United States
65 articles about Neurotech Pharmaceuticals
-
Alex Gorsky Joins Neurotech’s Board as Lead Director
9/13/2023
Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.
-
Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer
1/10/2023
Neurotech Pharmaceuticals, Inc., a clinical stage biotech company, today announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two decades of eyecare experience across both rare disease and specialty markets.
-
Neurotech Pharmaceuticals, Inc. Announces Positive Phase 3 Topline Results for NT-501 Implant in Macular Telangiectasia Type 2
11/2/2022
Neurotech Pharmaceuticals, Inc., a clinical stage biotech company, today announced positive topline results in two replicative Phase 3 clinical trials with their investigational encapsulated cell therapy (ECT) for the treatment of Macular telangiectasia type 2 (MacTel), an orphan, slowly progressive degenerative disease of the macula that results in gradual deterioration of central vision.
-
Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer
11/1/2021
Neurotech Pharmaceuticals announced today that Thomas Aaberg, Jr., M.D. has been appointed to the position of Chief Medical Officer (CMO).
-
Neurotech Release: Data Collection at U.S. Clinical Trial Completed, Analysis Underway
1/8/2018
Neurotech is pleased to announce that the US Clinical Trial for its Mente Autism device has been completed and analysis is underway.
-
PHARNEXT To Present At 4th International Neurotech Investing And Partnering Conference
9/29/2017
-
Deep Knowledge Ventures Expands Into Neurotech, Leading Seed Round For DeepWave Technologies Inc.
9/29/2017
-
Neurotech Release: Outstanding Preliminary Results From U.S. Clinical Study
9/27/2017
-
Neurotech Release: Turkey’s ESE Pazarlama Renews Contract With Three-Year Distribution Partner Agreement
6/26/2017
-
Neurotech Announces Positive Phase II Results In NT-501 (CNTF) For Macular Telangiectasia
6/20/2017
-
Neurotech Release: Medical Devices Specialist Attieh Medico To Distribute Mente Autism In Saudi Arabia
6/19/2017
-
Neurotech Release: Mente Autism Included On The Australian Register Of Therapeutic Goods
6/6/2017
-
Neurotech Release: 12-Week Therapy Session For Initial Cohort Of Subjects In U.S. Clinical Trial Nearing Completion
5/30/2017
-
Neurotech Release: First Shipment Of Mente Autism Devices To Greece
5/25/2017
-
Neurotech Secures Medical Devices Specialist VDT Psychologie- & Medizinvertrieb As Distribution Partner
5/22/2017
-
Neurotech Files Pre-Submission Package With The U.S. FDA
3/30/2017
-
Neurotech Release: Patient Enrolment Completed In U.S. Clinical Trial
3/29/2017
-
Neurotech Secures Leading Austrian Medical Devices Specialist As Distribution Partner
3/2/2017
-
Neurotech Achieves Major Milestone With First Shipment Of Mente Autism Devices
12/22/2016
-
Neurotech Announces Launch Of New Website
12/13/2016